(Total Views: 159)
Posted On: 09/20/2018 8:13:22 AM
Post# of 27125
$GALT Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial
chart>>>
https://stockcharts.com/h-sc/ui?s=GALT&p=...0915836636
Story
https://globenewswire.com/news-release/2018/0...Trial.html
chart>>>
https://stockcharts.com/h-sc/ui?s=GALT&p=...0915836636
Story
https://globenewswire.com/news-release/2018/0...Trial.html
(0)
(0)Scroll down for more posts ▼
